Serina Therapeutics, Inc. (SER)
$2.39-$0.06 (-2.38%) Today
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
https://www.serinatherapeutics.comSEC filings for SER on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 4 | 11,689 | $21K |
| Grant or award | 7 | 3,440,083 | |
| Other acquisition / disposition | 5 | 9,520,697 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
56 Form 4 filings on record, the earliest from Dec 19, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Farrell Simon - Director | Grant or award | Stock Option (right to buy) | 30,500 | $0.00 | - | |
| Stephen K. Brannan - Director | Open-market purchase | Common Stock | 1,000 | $2.03 | $2K | |
| Jay Venkatesan - Director | Other | Series A Convertible Preferred Stock | 96,525 | $2.25 | $217K | |
| Jay Venkatesan - Director | Open-market purchase | Common Stock | 589 | $1.78 | $1K | |
| Jay Venkatesan - Director | Other | Common Stock | 224,152 | $2.25 | $504K | |
| Jay Venkatesan - Director | Grant or award | Stock Option (right to buy) | 15,250 | $0.00 | - | |
| Gregory Bailey - Director | Grant or award | Stock Option (right to buy) | 15,250 | $0.00 | - | |
| Gregory Bailey - Director | Grant or award | Redeemable Warrants | 3,333,333 | $0.00 | - | |
| Gregory Bailey - Director | Other | Series A Convertible Preferred Stock | 762,548 | $2.25 | $1.72M | |
| Gregory Bailey - Director | Other | Common Stock | 1,770,805 | $2.25 | $3.98M | |
| Gregory Bailey - Director | Other | Common Stock | 6,666,667 | $2.25 | $15.00M | |
| Stephen K. Brannan - Director | Grant or award | Stock Option (right to buy) | 15,250 | $0.00 | - | |
| Karen J. Wilson - Director | Grant or award | Stock Option (right to buy) | 15,250 | $0.00 | - | |
| Richard Peter Marshall - Director | Grant or award | Stock Option (right to buy) | 15,250 | $0.00 | - | |
| Karen J. Wilson - Director | Open-market purchase | Common Stock | 5,000 | $1.77 | $9K | |
| Karen J. Wilson - Director | Open-market purchase | Common Stock | 5,100 | $1.75 | $9K | |
| Steven A. Ledger - Officer | Grant or award | Common Stock | 10,100 | $1.93 | $19K | |
 Srini Tenjarla - Officer | Grant or award | Stock Option (right to buy) | 85,558 | $0.00 | - | |
| Steven A. Ledger - Officer | Grant or award | Stock Option (right to buy) | 380,825 | $0.00 | - | |
 Gregory S. Curhan - Officer | Grant or award | Stock Option (right to buy) | 123,019 | $0.00 | - | |
| Randall Moreadith - Officer | Grant or award | Stock Option (right to buy) | 85,558 | $0.00 | - | |
| Karen J. Wilson - Director | Open-market purchase | Common Stock | 10,000 | $1.77 | $18K | |
| Karen J. Wilson - Director | Open-market purchase | Common Stock | 10,000 | $1.93 | $19K | |
| Richard Peter Marshall - Director | Open-market purchase | Common Stock | 12,183 | $1.65 | $20K | |
| Gregory Bailey - Director | Grant or award | Common Stock | 59,667 | $1.94 | $116K | |
| Jay Venkatesan - Director | Grant or award | Common Stock | 7,553 | $1.94 | $15K | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 6,500 | $0.06 | $390 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 6,500 | $2.86 | $19K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 6,500 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 39,000 | $0.06 | $2K | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 39,000 | $2.50 | $98K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 39,000 | $0.00 | - | |
| Randall Moreadith - Officer | Grant or award | Stock Option (right to buy) | 69,000 | $0.00 | - | |
| Srini Tenjarla - Officer | Grant or award | Stock Option (right to buy) | 69,000 | $0.00 | - | |
 Simba Gill - Director | Grant or award | Stock Option (right to buy) | 92,000 | $0.00 | - | |
| Steven A. Ledger - Officer | Grant or award | Stock Option (right to buy) | 230,100 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 6,500 | $0.06 | $390 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 6,500 | $3.03 | $20K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 6,500 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 6,500 | $0.06 | $390 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 6,500 | $3.57 | $23K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 6,500 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 2,500 | $0.06 | $150 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 2,500 | $2.95 | $7K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 2,500 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 2,000 | $0.06 | $120 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 2,000 | $3.07 | $6K | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 2,000 | $0.06 | $120 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 2,000 | $3.00 | $6K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 2,000 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 2,000 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 1,700 | $0.06 | $102 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 1,700 | $3.26 | $6K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 1,700 | $0.00 | - | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 1,500 | $3.91 | $6K | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 5,000 | $0.06 | $300 | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 1,500 | $0.06 | $90 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 5,000 | $3.52 | $18K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 1,500 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 5,000 | $0.00 | - | |
| Randall Moreadith - Officer | Option exercise | Common Stock | 5,965 | $0.06 | $358 | |
| Randall Moreadith - Officer | Open-market sale | Common Stock | 5,965 | $3.90 | $23K | |
| Randall Moreadith - Officer | Option exercise | Stock Option (right to buy) | 5,965 | $0.00 | - |
Serina Therapeutics, Inc. (SER) had 8 insider filings in the last 90 days, with the most recent on 2026-07-23. The full record for SER runs to 56 Form 4 filings, the earliest from 2024-12-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
4 insider purchases of SER were filed in the last 90 days, totaling $21K.
No insider sales of SER were filed in the last 90 days. 32 sales are on record for this company.
This page tracks SER Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add SER to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
